Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell-Free Plasma MicroRNA in Pancreatic Ductal Adenocarcinoma and Disease Controls

17 Sept 2013

Abstract excerpt

OBJECTIVES: There are no tumor-specific biochemical markers for pancreatic ductal adenocarcinoma (PDAC). Tissue-specific gene expression including microRNA (miRNA) profiling, however, identifies specific PDAC signatures. This study evaluates associations between circulating, cell-free plasma-miRNA profiles and PDAC in a disease and disease-control cohort. METHODS: We performed a microarray profiling of 847...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Pancreatic and Hepatic Oncology Research
Share to Pancreatitis Pathology and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24048453
DOI: 10.1097/mpa.0b013e318296bb34

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell-Free Plasma MicroRNA in Pancreatic Ductal Adenocarcinoma and Disease ControlsPMID 24048453Read ↗

Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort studySemantic proximity Read ↗

Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancerSemantic proximity Read ↗

Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From ControlsSemantic proximity Read ↗

A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

Clinical Potential of MicroRNAs in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Semantic proximity Read ↗

Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of diseaseSemantic proximity Read ↗

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancerSemantic proximity Read ↗

Experimental Validation of a Potential Circulating microRNA Panel for Non-Invasive Pancreatic Cancer DiagnosisSemantic proximity Read ↗

Circulating Cell-Free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non- malignant conditionsSemantic proximity Read ↗

Is Cell-Free DNA Testing in Pancreatic Ductal Adenocarcinoma Ready for Prime Time?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.